162 related articles for article (PubMed ID: 29411759)
1. [The clinical efficacy of allergen-specific immunotherapy with water-salt extracts and adjuvant allergens for atopic asthma with household sensitization].
Ushakova DV; Nikonov EL
Ter Arkh; 2017; 89(12):43-50. PubMed ID: 29411759
[TBL] [Abstract][Full Text] [Related]
2. ASIT as the component of bronchial asthma's therapy can improve the adherence to the treatment.
Besh O; Besh D; Sorkopud O; Kondratiuk M; Slaba O; Zhakun I; Strilchuk L; Ładny JR; Rafałowicz B; Szarpak Ł; Gałązkowski R; Nadolny K
Wiad Lek; 2018; 71(4):849-854. PubMed ID: 30099422
[TBL] [Abstract][Full Text] [Related]
3. [OPTIMIZATION OF ALLERGEN-SPECIFIC IMMUNOTHERAPY IN CHILDREN WITH BRONCHIAL ASTHMA: SELECTION FEATURES, PATIENT MONITORING AND EFFICACY].
Besh L; Slyuzar Z; Matsyura O
Georgian Med News; 2020 Sep; (306):67-72. PubMed ID: 33130649
[TBL] [Abstract][Full Text] [Related]
4. Dust mite-derived Enterobacterial fimbriae H protein enforces the allergen specific immunotherapy in asthma mice.
Yang X; Wang H; Zhao D; Wang J; Liu X; Yuan X; Zhang M; Li G; Ran P; Yang P; Liu Z
Allergol Immunopathol (Madr); 2020; 48(6):654-665. PubMed ID: 32446781
[TBL] [Abstract][Full Text] [Related]
5. Immunological changes after ASIT in AD allergen-specific immunotherapy and their potential correlation with clinical response in patients with atopic dermatitis patients sensitized to house dust mite.
Zhong H; Deng X; Song Z; Darsow U; Chen W; Chen S; Luo N; Hao F
J Eur Acad Dermatol Venereol; 2015 Jul; 29(7):1318-24. PubMed ID: 25376542
[TBL] [Abstract][Full Text] [Related]
6. [The impact of subcutaneous immunotherapy with Dermatophagoides farinae and Dermatophagoides pteronyssinus on the quality of life of patients with allergic rhinitis and asthma].
Yepes-Núñez JJ; Gómez C; Espinoza Y; Cardona R
Biomedica; 2014; 34(2):282-90. PubMed ID: 24967933
[TBL] [Abstract][Full Text] [Related]
7. Assessment of sublingual immunotherapy efficacy in children with house dust mite-induced allergic asthma optimally controlled by pharmacologic treatment and mite-avoidance measures.
Pham-Thi N; Scheinmann P; Fadel R; Combebias A; Andre C
Pediatr Allergy Immunol; 2007 Feb; 18(1):47-57. PubMed ID: 17295799
[TBL] [Abstract][Full Text] [Related]
8. Depigmented and polymerised house dust mite allergoid: allergen content, induction of IgG4 and clinical response.
Gallego MT; Iraola V; Himly M; Robinson DS; Badiola C; García-Robaina JC; Briza P; Carnés J
Int Arch Allergy Immunol; 2010; 153(1):61-9. PubMed ID: 20357486
[TBL] [Abstract][Full Text] [Related]
9. A recombinant
Babayeva M; Tabynov K; Nurpeisov T; Fomin G; Renukaradhya GJ; Petrovsky N; Tabynov K
Front Immunol; 2022; 13():983621. PubMed ID: 36439113
[TBL] [Abstract][Full Text] [Related]
10. Allergen-specific immunotherapy for atopic eczema: updated.
Darsow U
Curr Opin Allergy Clin Immunol; 2012 Dec; 12(6):665-9. PubMed ID: 22918221
[TBL] [Abstract][Full Text] [Related]
11. House dust mite sublingual immunotherapy is safe in patients with mild-to-moderate, persistent asthma: a clinical trial.
Devillier P; Fadel R; de Beaumont O
Allergy; 2016 Feb; 71(2):249-57. PubMed ID: 26465232
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial.
Virchow JC; Backer V; Kuna P; Prieto L; Nolte H; Villesen HH; Ljørring C; Riis B; de Blay F
JAMA; 2016 Apr; 315(16):1715-25. PubMed ID: 27115376
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of sublingual immunotherapy with high-dose mite extracts in asthma: a multi-center, double-blind, randomized, and placebo-controlled study in Taiwan.
Niu CK; Chen WY; Huang JL; Lue KH; Wang JY
Respir Med; 2006 Aug; 100(8):1374-83. PubMed ID: 16403616
[TBL] [Abstract][Full Text] [Related]
14. Injection allergen immunotherapy for asthma.
Abramson MJ; Puy RM; Weiner JM
Cochrane Database Syst Rev; 2010 Aug; (8):CD001186. PubMed ID: 20687065
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of allergen immunotherapy: what do we expect?
Frati F; Dell'Albani I; Incorvaia C
Immunotherapy; 2013 Feb; 5(2):131-3. PubMed ID: 23413904
[TBL] [Abstract][Full Text] [Related]
17. [Clinical efficacy of a standardized specific immunotherapy against house dust mite in 85 asthmatic children].
Zhang X; Li MR; Wang C; Wang XN; Zhang HL; Lin J; Jin K; Li YC
Zhonghua Er Ke Za Zhi; 2010 Jul; 48(7):526-30. PubMed ID: 21055090
[TBL] [Abstract][Full Text] [Related]
18. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis.
Wang ZX; Shi H
J Huazhong Univ Sci Technolog Med Sci; 2017 Jun; 37(3):407-411. PubMed ID: 28585143
[TBL] [Abstract][Full Text] [Related]
19. Long-term efficacy of allergen specific immunotherapy in atopic dermatitis patients in relation to quality of life.
Wyrzykowska N; Czarnecka-Operacz M; Adamski Z
Eur Ann Allergy Clin Immunol; 2015 Jan; 47(1):5-9. PubMed ID: 25599552
[TBL] [Abstract][Full Text] [Related]
20. Effect of specific immunotherapy added to pharmacologic treatment and allergen avoidance in asthmatic patients allergic to house dust mite.
Maestrelli P; Zanolla L; Pozzan M; Fabbri LM;
J Allergy Clin Immunol; 2004 Apr; 113(4):643-9. PubMed ID: 15100667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
